H
Hyo Keun Lim
Researcher at Samsung Medical Center
Publications - 279
Citations - 13027
Hyo Keun Lim is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Radiofrequency ablation & Ablation. The author has an hindex of 62, co-authored 276 publications receiving 11816 citations. Previous affiliations of Hyo Keun Lim include Sungkyunkwan University & Hallym University.
Papers
More filters
Journal ArticleDOI
Major Complications after Radio-frequency Thermal Ablation of Hepatic Tumors: Spectrum of Imaging Findings
Hyunchul Rhim,Kwon Ha Yoon,Jeong Min Lee,Yoonkoo Cho,June Sik Cho,Seung Hoon Kim,Won Jae Lee,Hyo Keun Lim,Gyoung Jin Nam,Sang Suk Han,Yun Hwan Kim,Cheolmin Park,Pyo Nyun Kim,Jae Young Byun +13 more
TL;DR: A physician who performs RF ablation of hepatic malignancies should be aware of the broad spectrum of major complications so that these strategies can be used.
Journal ArticleDOI
Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors.
Hyunchul Rhim,S. Nahum Goldberg,Gerald D. Dodd,Luigi Solbiati,Hyo Keun Lim,Massimo Tonolini,On Koo Cho +6 more
TL;DR: Essential technical tips to successful radio-frequency ablation therapy were collected from five international experts and will be very helpful for physicians performing radio- frequencies ablation of hepatic tumors.
Journal ArticleDOI
Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: Analysis of prognostic factors
Young-sun Kim,Hyo Keun Lim,Hyunchul Rhim,Min Woo Lee,Dongil Choi,Won Jae Lee,Seung Woon Paik,Kwang Cheol Koh,Joon Hyeok Lee,Moon Seok Choi,Geum-Youn Gwak,Byung Chul Yoo +11 more
TL;DR: Ten-year survival outcomes after percutaneous radiofrequency ablation as a first-line therapy of hepatocellular carcinoma were excellent despite frequent tumor recurrences, and overall survival was influenced by age, Child-Pugh class, antiviral therapy, or extrahepatic recurrence.
Journal ArticleDOI
Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series.
Dongil Choi,Hyo Keun Lim,Hyunchul Rhim,Young-sun Kim,Won Jae Lee,Seung Woon Paik,Kwang Cheol Koh,Joon Hyoek Lee,Moon Seok Choi,Byung Chul Yoo +9 more
TL;DR: Percutaneous RFA can be used successfully as a first-line treatment modality for early-stage HCCs and Child-Pugh class, age, and AFP level before RFA were significant prognostic predictors of long-term survival.
Journal ArticleDOI
Gadoxetic Acid–Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma
Seong Hyun Kim,Seung Hoon Kim,Jongmee Lee,Min Ju Kim,Yong Hwan Jeon,Yulri Park,Dongil Choi,Won Jae Lee,Hyo Keun Lim +8 more
TL;DR: Gadoxetic acid-enhanced MRI and triple-phase MDCT have similar diagnostic performance in the preoperative detection of HCC, but MRI may be better than MDCT in the detection ofHCC 1 cm in diameter or smaller.